Search

Author/Creator Lothgren, Mickael

1. Cost per patient and potential budget implications of denosumab compared with zoledronic acid in adults with bone metastases from solid tumours who are at risk of skeletal-related events: an analysis for Austria, Sweden and Switzerland. Issue 4 (21st February 2013)

Authors:
Lothgren, Mickael; Ribnicsek, Erna; Schmidt, Louise; Habacher, Wolfgang; Lundkvist, Jonas; Pfeil, Alena M; Biteeva, Irina; Vrouchou, Polina; Bracco, Andrea
Journal:
European journal of hospital pharmacy
Issue:
Volume 20:Issue 4(2013)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic. (3rd August 2017)

Authors:
Cristino, Joaquim; Finek, Jíndřich; Jandova, Petra; Kolek, Martin; Pásztor, Bálint; Giannopoulou, Christina; Qian, Yi; Brezina, Tomas; Lothgren, Mickael
Journal:
Journal of medical economics
Issue:
Volume 20:Number 8(2017)
Page Start:
799
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗